NatureCell Co.,Ltd. (KOSDAQ:007390)
South Korea · Delayed Price · Currency is KRW 18,870
+370 (2.00%)
Apr 10, 2026, 3:30 PM KST
NatureCell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 20,735 | 32,334 | 19,351 | 21,252 | 20,354 |
Other Revenue | -0 | -0 | - | - | -0 |
| 20,735 | 32,334 | 19,351 | 21,252 | 20,354 | |
Revenue Growth (YoY) | -35.87% | 67.09% | -8.95% | 4.41% | -25.18% |
Cost of Revenue | 11,281 | 15,414 | 11,160 | 12,163 | 11,114 |
Gross Profit | 9,454 | 16,920 | 8,191 | 9,089 | 9,241 |
Selling, General & Admin | 11,566 | 14,505 | 15,112 | 16,454 | 15,052 |
Research & Development | 64.37 | 338.9 | 2,221 | 1,577 | 1,473 |
Amortization of Goodwill & Intangibles | 10.37 | 6.11 | 4.31 | 3.85 | 3.2 |
Other Operating Expenses | 127 | 63.2 | 50.33 | 87.35 | -66.38 |
Operating Expenses | 13,100 | 16,316 | 18,411 | 15,785 | 17,706 |
Operating Income | -3,646 | 604.01 | -10,220 | -6,696 | -8,465 |
Interest Expense | -200.49 | -168.04 | -1,147 | -1,724 | -750.69 |
Interest & Investment Income | 624.13 | 859.8 | 731.36 | 343.37 | 92.11 |
Earnings From Equity Investments | - | - | -61.21 | -1,106 | -360.01 |
Currency Exchange Gain (Loss) | 611.63 | 255.71 | 92.35 | 44.94 | 91.76 |
Other Non Operating Income (Expenses) | -116.88 | -196.51 | -838.02 | -918.18 | -15,896 |
EBT Excluding Unusual Items | -2,728 | 1,355 | -11,443 | -10,055 | -25,289 |
Gain (Loss) on Sale of Investments | - | - | -357.21 | 1,710 | -4,156 |
Gain (Loss) on Sale of Assets | -39.16 | -0.05 | 276.5 | 29.36 | - |
Asset Writedown | - | - | - | - | -569.55 |
Other Unusual Items | - | - | -47.43 | - | - |
Pretax Income | -2,767 | 1,355 | -11,571 | -8,316 | -30,014 |
Income Tax Expense | 71.61 | 128.77 | -132.64 | - | - |
Earnings From Continuing Operations | -2,838 | 1,226 | -11,438 | -8,316 | -30,014 |
Earnings From Discontinued Operations | - | - | -242.25 | 1,502 | -2,016 |
Net Income | -2,838 | 1,226 | -11,680 | -6,814 | -32,031 |
Net Income to Common | -2,838 | 1,226 | -11,680 | -6,814 | -32,031 |
Shares Outstanding (Basic) | 64 | 64 | 64 | 63 | 62 |
Shares Outstanding (Diluted) | 64 | 64 | 64 | 63 | 62 |
Shares Change (YoY) | 0.11% | 1.23% | 1.46% | 1.43% | 143.89% |
EPS (Basic) | -44.07 | 19.09 | -183.80 | -108.78 | -518.71 |
EPS (Diluted) | -44.07 | 19.06 | -183.80 | -108.78 | -518.71 |
Free Cash Flow | -16,386 | -1,590 | -8,253 | -18,659 | -10,533 |
Free Cash Flow Per Share | -254.43 | -24.72 | -129.86 | -297.89 | -170.58 |
Gross Margin | 45.60% | 52.33% | 42.33% | 42.77% | 45.40% |
Operating Margin | -17.58% | 1.87% | -52.81% | -31.51% | -41.59% |
Profit Margin | -13.69% | 3.79% | -60.36% | -32.06% | -157.37% |
Free Cash Flow Margin | -79.03% | -4.92% | -42.65% | -87.80% | -51.75% |
EBITDA | -1,818 | 2,504 | -8,469 | -5,364 | -6,617 |
EBITDA Margin | -8.77% | 7.74% | -43.77% | -25.24% | -32.51% |
D&A For EBITDA | 1,828 | 1,900 | 1,751 | 1,332 | 1,848 |
EBIT | -3,646 | 604.01 | -10,220 | -6,696 | -8,465 |
EBIT Margin | -17.58% | 1.87% | -52.81% | -31.51% | -41.59% |
Effective Tax Rate | - | 9.50% | - | - | - |
Advertising Expenses | 731.47 | 2,943 | 3,185 | 543.12 | 1,904 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.